DCGI panel to review today SII applications for Covovax’s use among kids aged 2-7 years, 7-11 years Read more
SII seeks market authorisation from DCGI for India’s first qHPV vaccine against cervical cancer Read more
SII and Symbiosis International University sign MoU to set up research centre for vaccine and biologicals Read more